Ecography, diagnostic technique in non-alcoholic hepatic esteatosis
DOI:
https://doi.org/10.19230/jonnpr.3261Keywords:
Hepatic steatosis, Liver ultrasound, Obesity, Cardiovascular risk factorsAbstract
Objective. To analyze the ultrasound as a diagnostic test for non-alcoholic liver steatosis.
Method. Observational, descriptive and analytical study, of cross section. For 12 months, 100 patients were selected, with 2 or more cardiovascular risk factors, with no or low alcohol intake, who attended Primary Care. Determinations made. Demographic and biochemical variables: Age. Gender. Alcohol intake. History of diabetes, systemic arterial hypertension. Weight, height, body mass index (BMI). Blood pressure measurement Basal glucose levels, glycosylated hemoglobin. Total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, AST, ALT, bilirubins and alkaline phosphatase. Personal and family history of diabetes, HBP, dyslipidemia, drug treatment, figures of other analytical parameters and abdominal perimeter were also collected. Hepatic evaluation by ultrasonography. Once they met the selection criteria, they were cited for the realization of the ultrasound of the entire abdomen, prior information on the purpose of the technique to be performed and providing the signed informed consent. The ultrasound was performed with the patient on an empty stomach and, if possible, with a bladder replenished, in order to perform the technique in the best conditions of preparation of the patient, in order to reduce the ultrasound devices and to assess all the abdominal structures correctly. Statistical Analysis with SPSS program 23. The qualitative variables are shown as exact value and in percentage, the quantitative variables as mean and standard deviation (SD). The comparison between means was made through the Student t test for independent groups or the Mann-Whitney U test if the normal conditions (application of the Kolmogorov-Smirnoff or Shapiro Willks test) were not met. In qualitative variables, the chi-square test.
Results. 100 patients participated: 44 men and 56 women, with a mean age of 61.84. 71% of subjects are obese. 23% of the subjects do not have steatosis, and in 58% it is mild and moderate in both genders (p <0.003). 19% have grade 3 steatosis. The most prevalent risk factors of the patients studied are obesity, which is presented by 78% of them, hypercholesterolemia 73%, DM 62% and HT 59%.
Conclusions. Ultrasound is the modality of choice for the qualitative determination of steatosis, but it is a subjective and operator-dependent test: it only detects moderate to severe fat infiltration.
Downloads
References
Barba JR. Esteatosis hepática, esteatohepatitis y marcadores de lesión hepática. Rev. Mex. Patol. Clin. 2008; 55:216-232.
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study. Hepatology. 2005; 42:44-52.
Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000; 32:112-7.
Parés A, Tresserras R, Núñez I, Cerralbo M, Plana P, Pujol FJ, et al. Prevalencia y factores aso ciados a la presencia de esteatosis hepática en varones adultos aparentemente sanos. Med Clin (Barc). 2000; 114:561-5.
Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. J Hepatol. 2007; 47:239-44.
Marín E, Segura JM. Utilidad de la ultrasonografía en el diagnóstico de las enfermedades hepáticas difusas. Rev Esp Enferm Dig. 2011; 103:227-31.
García C. Enfermedad hepática grasa no alcohólica. En: Montoro MA, García JC, editores. Gastroenterología y hepatología. Problemas comunes en la práctica clínica. Madrid. Jarpyo editores. 2012; 56:815-24.
Ricote G, García C. Estado actual de la esteatohepatitis no alcohólica. Med Clin (Barc). 2003; 121:102-8.
Pan J, Fallon M. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014; 6:274- 83.
Terán A, Crespo J. Cribado de la enfermedad hepática por depósito de grasa: cómo y a quién. Gastroenterol Hepatol. 2011; 34:278-88.
Brunt EM, Kleiner DE, Wilson L.A, Belt P, Neuschwander-Tetri BA. NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011; 53:810-20.
Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014; 20:39-48
Stranges S, Dorn JM, Muti P, Freudenheim JL, Farinaro E, Russell M, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology. 2004; 39:754–763.
Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty lier. Hepatology. 2004; 39: 179-87.
García G, Torres J. Manual de ecografía clínica. Hígado: SEMI; 2012;8: 51-61.
Díaz N, Acuña A. Principios físicos de la ecografía. Semergen. 2003; 29:75-97.
Martín A, Castellano G. Seguimiento ecográfico de los pacientes con hepatopatía crónica. Rev Esp Ecografía Dig. 2006; 8:1-10.
Ruales F, Barbano J, Gómez E. Infiltración grasa hepática difusa y su correlación con el índice de masa corporal, los triglicéridos y las transaminasas. Acta Gastroenterol Latinoam. 2012; 42:278-84.
Caballería L, Torán P, Auladell A, Pera G .Esteatosis hepática no alcohólica. Puesta al día. Aten Primaria. 2008; 40:419-24.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License